Protecting Patient Access to Cancer and Complex Therapies Act of 2023

Read twice and referred to the Committee on Finance.

• HR 5391 Protecting Patient Access to Cancer and Complex Therapies Act

• Introduced in Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

• Finance Committee
  Senate

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

• BIOTECHNOLOGY INNOVATION ORGANIZATION
  for BIOTECHNOLOGY INNOVATION ORGANIZATION · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• NOVARTIS
  for NOVARTIS · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• HEALTHCARE INSTITUTE OF NEW JERSEY
  for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 3rd Quarter 2026 (July 1 - Sep 30)
• BIOTECHNOLOGY INNOVATION ORGANIZATION
  for BIOTECHNOLOGY INNOVATION ORGANIZATION · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
• NOVARTIS
  for NOVARTIS · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
• HEALTHCARE INSTITUTE OF NEW JERSEY
  for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 2nd Quarter 2026 (Apr 1 - June 30)

Bodies those filers lobbied

• HOUSE OF REPRESENTATIVES
  17 filings
• SENATE
  17 filings
• Health & Human Services, Dept of (HHS)
  13 filings
• Commerce, Dept of (DOC)
  9 filings
• White House Office
  8 filings
• Office of Management & Budget (OMB)
  6 filings
• Patent & Trademark Office (PTO)
  6 filings
• Centers For Medicare and Medicaid Services (CMS)
  5 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.